All data are based on the daily closing price as of April 24, 2026
g
Grape King Bio
1707.TW
3.70 USD
0.01
+0.27%
Overview
Last close
3.70 usd
Market cap
548.38M usd
52 week high
4.87 usd
52 week low
3.69 usd
Target price
4.39 usd
Valuation
P/E
14.2595
Forward P/E
17.3611
Price/Sales
1.6834
Price/Book Value
1.6688
Enterprise Value
419.70M usd
EV/Revenue
1.2872
EV/EBITDA
4.6154
Key financials
Revenue TTM
326.07M usd
Gross Profit TTM
244.81M usd
EBITDA TTM
82.62M usd
Earnings per Share
0.26 usd
Dividend
N/A usd
Total assets
501.40M usd
Net debt
-125.83M usd
About
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.